Skip to content

A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer

A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer - A Prospective, Multi-center Investigation of the performance of Endo GIA Reinforced Reload with Tri-Staple Technology in Gastrectomy for Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014398
Enrollment
100
Registered
2014-06-27
Start date
2014-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

None listed

Sponsors

Aichi Cancer Center Hospital, Department of Gastrointestinal Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with gastric cancer planned to undergo open or laparoscopic (distal or total) gastrectomy with Roux-en-Y reconstruction using a surgical stapling device 2)Patients aged 20 years or older 3)Patients with no history of upper abdominal surgery (with the exception of laparoscopic cholecystectomy) 4)Patients with an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1 5)Patients with adequate functions of major organs 6)Patients who have provided written informed consent in person for participation in the study

Exclusion criteria

Exclusion criteria: 1)Women who are pregnant or possibly pregnant, or breastfeeding 2)Patients receiving continuous systemic (oral or intravenous) steroid therapy 3)Patients with concurrent diabetes mellitus with poor control (HbA1c > 8.0%) 4)Patients with a history of allergy to nickel or chrome (a contraindication in IFU) 5)Patients with concurrent mental disorder or psychiatric symptoms judged to preclude participation in this study 6)Other patients judged by the investigator to be inappropriate as a subject of this study

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative duodenal stump leakage

Secondary

MeasureTime frame
Staple line hemostasis, any staple malformation, incidence of serosal injury, any additional suturing, amount of blood loss, duration of surgery, incidence of intraoperative and postoperative adverse events, duration of drain placement, duration of hospital stay

Countries

Japan

Contacts

Public ContactKazunari Misawa

Aichi Cancer Center Hospital Department of Gastrointestinal Surgery

misawakzn@aichi-cc.jp052-762-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026